JP2000501697A5 - - Google Patents

Download PDF

Info

Publication number
JP2000501697A5
JP2000501697A5 JP1997507005A JP50700597A JP2000501697A5 JP 2000501697 A5 JP2000501697 A5 JP 2000501697A5 JP 1997507005 A JP1997507005 A JP 1997507005A JP 50700597 A JP50700597 A JP 50700597A JP 2000501697 A5 JP2000501697 A5 JP 2000501697A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997507005A
Other languages
English (en)
Japanese (ja)
Other versions
JP4125369B2 (ja
JP2000501697A (ja
Filing date
Publication date
Priority claimed from AUPN4492A external-priority patent/AUPN449295A0/en
Application filed filed Critical
Publication of JP2000501697A publication Critical patent/JP2000501697A/ja
Publication of JP2000501697A5 publication Critical patent/JP2000501697A5/ja
Application granted granted Critical
Publication of JP4125369B2 publication Critical patent/JP4125369B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP50700597A 1995-07-28 1996-07-26 放射線防護剤 Expired - Lifetime JP4125369B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU4492 1982-06-18
AUPN4492A AUPN449295A0 (en) 1995-07-28 1995-07-28 Radioprotectors
PCT/AU1996/000467 WO1997004776A1 (en) 1995-07-28 1996-07-26 Radioprotectors

Publications (3)

Publication Number Publication Date
JP2000501697A JP2000501697A (ja) 2000-02-15
JP2000501697A5 true JP2000501697A5 (enExample) 2004-08-26
JP4125369B2 JP4125369B2 (ja) 2008-07-30

Family

ID=3788827

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50700597A Expired - Lifetime JP4125369B2 (ja) 1995-07-28 1996-07-26 放射線防護剤

Country Status (9)

Country Link
US (2) US6194414B1 (enExample)
EP (2) EP0857067A4 (enExample)
JP (1) JP4125369B2 (enExample)
AU (2) AUPN449295A0 (enExample)
CA (1) CA2228044C (enExample)
DK (1) DK2044938T3 (enExample)
ES (1) ES2537054T3 (enExample)
PT (1) PT2044938E (enExample)
WO (1) WO1997004776A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006831A1 (en) * 1994-08-26 1996-03-07 Auckland Division Cancer Society Of New Zealand Inc. Novel dna-targeted alkylating agents
EP1465882B1 (en) * 2001-12-21 2011-08-24 X-Ceptor Therapeutics, Inc. Hetrocyclic modulators of nuclear receptors
US7288559B2 (en) * 2003-03-14 2007-10-30 Merck + Co, Inc. Carboxamide spirohydantoin CGRP receptor antagonists
CA2519475A1 (en) 2003-03-14 2004-09-30 Merck & Co., Inc. Bicyclic anilide spirohydantoin cgrp receptor antagonists
WO2005082894A1 (en) * 2004-02-27 2005-09-09 Peter Maccallum Cancer Institute Cell targeting conjugates
BRPI0512261A (pt) * 2004-06-17 2008-02-26 Wyeth Corp antagonistas de receptor de hormÈnio liberador de gonadotropina
BRPI0512239A (pt) * 2004-06-17 2008-02-19 Wyeth Corp processos para preparação de antagonistas de receptores de hormÈnios liberadores de gonatropina
CN101098854B (zh) 2004-07-23 2012-12-05 恩多塞特公司 二价连接体及其轭合物
EP1793827B1 (en) * 2004-09-09 2010-04-07 Merck Sharp & Dohme Corp. Tricyclic anilide spirolactam cgrp receptor antagonists
EP1814866A2 (en) * 2004-11-23 2007-08-08 Wyeth a Corporation of the State of Delaware Gonadotropin releasing hormone receptor antagonists
US7582634B2 (en) * 2005-02-18 2009-09-01 Wyeth 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7534796B2 (en) * 2005-02-18 2009-05-19 Wyeth Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
US7538113B2 (en) * 2005-02-18 2009-05-26 Wyeth 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US20060189619A1 (en) * 2005-02-24 2006-08-24 Wyeth 3-({4-[2-(4-Tert-butylphenyl)-1h-benzimidazol-4-yl]piperazin-1-yl}methyl)pyrido[2,3-b]]pyrazi ne compounds
DE102005019549A1 (de) * 2005-04-25 2006-12-14 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Diaminobenzimidazol
US7531542B2 (en) 2005-05-18 2009-05-12 Wyeth Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US7582636B2 (en) * 2005-05-26 2009-09-01 Wyeth Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
US8093401B2 (en) 2005-08-04 2012-01-10 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
US8088928B2 (en) 2005-08-04 2012-01-03 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
US7855289B2 (en) 2005-08-04 2010-12-21 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
AU2006278504B2 (en) 2005-08-04 2013-01-17 Sirtris Pharmaceuticals, Inc. Imidazopyridine derivatives as sirtuin modulating agents
WO2008073451A2 (en) * 2006-12-11 2008-06-19 Sirtris Pharmaceuticals, Inc. Benzoimidazole derivatives as sirtuin (sir) modulating compounds
PT2114896E (pt) 2006-12-21 2015-11-04 Peter Maccallum Cancer Inst Compostos radio-protetores e métodos relacionados
WO2008112873A2 (en) 2007-03-14 2008-09-18 Endocyte, Inc. Binding ligand linked drug delivery conjugates of tubulysins
CL2008001822A1 (es) 2007-06-20 2009-03-13 Sirtris Pharmaceuticals Inc Compuestos derivados de tiazolo[5,4-b]piridina; composicion farmaceutica que comprende a dichos compuestos; y uso del compuesto en el tratamiento de la resistencia a la insulina, sindrome metabolico, diabetes, entre otras.
EP3569251A1 (en) 2007-06-25 2019-11-20 Endocyte, Inc. Conjugates containing hydrophilic spacer linkers
US9877965B2 (en) 2007-06-25 2018-01-30 Endocyte, Inc. Vitamin receptor drug delivery conjugates for treating inflammation
CN102388054B (zh) 2008-12-19 2015-03-04 西特里斯药业公司 噻唑并吡啶沉默调节蛋白调节剂的化合物
EP2556058B1 (en) 2010-04-06 2017-06-14 Peter MacCallum Cancer Institute Radioprotector compounds and methods
WO2013126797A1 (en) 2012-02-24 2013-08-29 Purdue Research Foundation Cholecystokinin b receptor targeting for imaging and therapy
US20140080175A1 (en) 2012-03-29 2014-03-20 Endocyte, Inc. Processes for preparing tubulysin derivatives and conjugates thereof
HK1212618A1 (zh) 2012-10-16 2016-06-17 恩多塞特公司 含有非天然氨基酸的藥物遞送綴合物以及其使用方法
JP6676650B2 (ja) * 2015-03-13 2020-04-08 エンドサイト・インコーポレイテッドEndocyte, Inc. 疾患を処置するためのコンジュゲート
GB201506660D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds
GB201506658D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds
RU205631U1 (ru) * 2021-01-11 2021-07-23 Общество с ограниченной ответственностью "Газпром добыча Уренгой" Устройство для поверки и калибровки средств измерений малого давления

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670684A1 (de) * 1966-04-01 1970-12-03 Hoechst Ag Verfahren zur Herstellung von basisch substituierten Bis-benzimidazol-derivaten
WO1990012321A1 (en) * 1989-03-31 1990-10-18 The Cancer Institute Board Halogenated dna ligand radiosensitisers for cancer therapy
US5641764A (en) * 1989-03-31 1997-06-24 Peter Maccallum Institute Halogenated DNA ligand radiosensitizers for cancer therapy

Similar Documents

Publication Publication Date Title
JP2000515114A5 (enExample)
JP2000500228A5 (enExample)
JP2000500445A5 (enExample)
JP2000500033A5 (enExample)
JP2000500440A5 (enExample)
JP2000500327A5 (enExample)
JP2000516195A5 (enExample)
JP2000500145A5 (enExample)
JP2000500155A5 (enExample)
JP2000500406A5 (enExample)
JP2000500115A5 (enExample)
JPH11512513A5 (enExample)
JP2000500322A5 (enExample)
JP2000500258A5 (enExample)
JP2000500192A5 (enExample)
JP2000500112A5 (enExample)
JP2000500226A5 (enExample)
JP2000500407A5 (enExample)
JP2000500397A5 (enExample)
JP2000501697A5 (enExample)
JP2000500166A5 (enExample)
JP2000514177A5 (enExample)
JP2001516440A5 (enExample)
JP2000500125A5 (enExample)
JP2000500044A5 (enExample)